Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-08-05

Clinical Trial Update: Randomized Double-Blind Placebo-Controlled Crab or Shrimp Allergy Reduction Study Using Nambudripad Allergy Elimination Techniques [NA]

View source ↗

Summary

Trial update for a randomized, double-blind, placebo-controlled study evaluating Nambudripad Allergy Elimination Techniques to reduce crab or shrimp allergy. Sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Food Allergies | NA | Status: UNKNOWN